219 related articles for article (PubMed ID: 32592484)
1. JAM-A functions as a female microglial tumor suppressor in glioblastoma.
Turaga SM; Silver DJ; Bayik D; Paouri E; Peng S; Lauko A; Alban TJ; Borjini N; Stanko S; Naik UP; Keri RA; Connor JR; Barnholtz-Sloan JS; Rubin JB; Berens M; Davalos D; Lathia JD
Neuro Oncol; 2020 Nov; 22(11):1591-1601. PubMed ID: 32592484
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
[TBL] [Abstract][Full Text] [Related]
3. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
4. Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.
Kiss M; Lebegge E; Murgaski A; Van Damme H; Kancheva D; Brughmans J; Scheyltjens I; Talebi A; Awad RM; Elkrim Y; Bardet PMR; Arnouk SM; Goyvaerts C; Swinnen J; Nana FA; Van Ginderachter JA; Laoui D
Front Immunol; 2022; 13():1003975. PubMed ID: 36531986
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
[No Abstract] [Full Text] [Related]
6. Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells.
Fan D; Yue Q; Chen J; Wang C; Yu R; Jin Z; Yin S; Wang Q; Chen L; Liao X; Peng C; Zhang J; Cao Z; Mao Y; Huang R; Chen L; Li C
Oncoimmunology; 2021 Jun; 10(1):1932061. PubMed ID: 34123575
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
[TBL] [Abstract][Full Text] [Related]
8. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
9. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment.
Yin Y; Qiu S; Li X; Huang B; Xu Y; Peng Y
J Neuroinflammation; 2017 Nov; 14(1):220. PubMed ID: 29132376
[TBL] [Abstract][Full Text] [Related]
10. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA
Amaral RF; Geraldo LHM; Einicker-Lamas M; E Spohr TCLS; Mendes F; Lima FRS
J Neurochem; 2021 Feb; 156(4):499-512. PubMed ID: 32438456
[TBL] [Abstract][Full Text] [Related]
11. Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.
Dumas AA; Pomella N; Rosser G; Guglielmi L; Vinel C; Millner TO; Rees J; Aley N; Sheer D; Wei J; Marisetty A; Heimberger AB; Bowman RL; Brandner S; Joyce JA; Marino S
EMBO J; 2020 Aug; 39(15):e103790. PubMed ID: 32567735
[TBL] [Abstract][Full Text] [Related]
12. Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression.
Lauko A; Mu Z; Gutmann DH; Naik UP; Lathia JD
Cancer Res; 2020 Nov; 80(22):4878-4885. PubMed ID: 32816855
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment and Immune Escape in the Time Course of Glioblastoma.
Virtuoso A; De Luca C; Cirillo G; Riva M; Romano G; Bentivegna A; Lavitrano M; Papa M; Giovannoni R
Mol Neurobiol; 2022 Nov; 59(11):6857-6873. PubMed ID: 36048342
[TBL] [Abstract][Full Text] [Related]
14. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
15. High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor.
Lathia JD; Li M; Sinyuk M; Alvarado AG; Flavahan WA; Stoltz K; Rosager AM; Hale J; Hitomi M; Gallagher J; Wu Q; Martin J; Vidal JG; Nakano I; Dahlrot RH; Hansen S; McLendon RE; Sloan AE; Bao S; Hjelmeland AB; Carson CT; Naik UP; Kristensen B; Rich JN
Cell Rep; 2014 Jan; 6(1):117-29. PubMed ID: 24373972
[TBL] [Abstract][Full Text] [Related]
16. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction.
Resende FF; Bai X; Del Bel EA; Kirchhoff F; Scheller A; Titze-de-Almeida R
BMC Cancer; 2016 Feb; 16():72. PubMed ID: 26856327
[TBL] [Abstract][Full Text] [Related]
19. Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice.
Poli A; Oudin A; Muller A; Salvato I; Scafidi A; Hunewald O; Domingues O; Nazarov PV; Puard V; Baus V; Azuaje F; Dittmar G; Zimmer J; Michel T; Michelucci A; Niclou SP; Ollert M
Allergy; 2023 Mar; 78(3):682-696. PubMed ID: 36210648
[TBL] [Abstract][Full Text] [Related]
20. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E
Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
